DeepMed Research

University of Guadalajara

🇲🇽Mexico

Country: 🇲🇽Mexico

Ownership: Private

Established: 1792-01-01

Employees: -

Market Cap: -

Website: http://www.udg.mx

Clinical Trials

Effect of Fucoxanthin on the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion

Phase 2

Completed

Conditions: Metabolic Syndrome

Interventions: Drug: Placebo
Drug: Fucoxanthin

First Posted Date: 2018-08-03

Last Posted Date: 2024-11-21

Lead Sponsor: University of Guadalajara

Target Recruit Count: 28

Registration Number: NCT03613740

Locations: 🇲🇽
Instituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara, Guadalajara, Jalisco, Mexico

Effect of Dihydromirycetin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes Mellitus

Phase 2

Active, not recruiting

Conditions: Type 2 Diabetes Mellitus

Interventions: Drug: Dihydromyricetin
Drug: Metformin

First Posted Date: 2018-07-31

Last Posted Date: 2023-05-23

Lead Sponsor: University of Guadalajara

Target Recruit Count: 24

Registration Number: NCT03606694

Locations: 🇲🇽
Instituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara, Guadalajara, Jalisco, Mexico

Dapagliflozin on Blood Pressure Variability and Ambulatory Arterial Stiffness Index in Hypertension

Phase 4

Conditions: Hypertension

Interventions: Drug: Placebo - Cap
Drug: Dapagliflozin

First Posted Date: 2018-07-19

Last Posted Date: 2020-12-28

Lead Sponsor: University of Guadalajara

Target Recruit Count: 20

Registration Number: NCT03592667

Locations: 🇲🇽
Instituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara, Guadalajara, Jalisco, Mexico

Effect of Exenatide LAR or Dulaglutide on the Variability of 24-hour Heart Rate and Blood Pressure in Type 2 Diabetes

Phase 4

Conditions: Diabetes Mellitus, Type 2

Interventions: Drug: Exenatide LAR
Drug: Dulaglutide

First Posted Date: 2018-02-23

Last Posted Date: 2020-03-26

Lead Sponsor: University of Guadalajara

Target Recruit Count: 30

Registration Number: NCT03444142

Locations: 🇲🇽
Instituto de terapeutica Experimental y Clinica. Centro universitario de Ciencias de la Salud. Universidad de Guadalajara, Guadalajara, Jalisco, Mexico

Effect of the Administration of L-Carnitine on Body Weight in Women in Crossfit Training

Phase 2

Conditions: Body Weight Changes

Interventions: Dietary Supplement: Sucralose
Drug: L-Carnitine

First Posted Date: 2018-02-19

Last Posted Date: 2018-02-20

Lead Sponsor: University of Guadalajara

Target Recruit Count: 24

Registration Number: NCT03436277

Locations: 🇲🇽
Centro Universitario de Tonalá, Tonalá, Jalisco, Mexico

Effect of Propolis or Metformin Administration on Glycemic Control in Patients With Type 2 Diabetes Mellitus

Phase 2

Completed

Conditions: Diabetes Mellitus, Type 2

Interventions: Drug: Placebo
Drug: Metformin
Drug: Propolis

First Posted Date: 2018-01-30

Last Posted Date: 2022-11-07

Lead Sponsor: University of Guadalajara

Target Recruit Count: 36

Registration Number: NCT03416127

Locations: 🇲🇽
Intstituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara, Guadalajara, Jalisco, Mexico

Chitosan Scaffold for Sellar Floor Repair in Endoscopic Endonasal Transsphenoidal Surgery

Not Applicable

Completed

Conditions: Csf Leakage

Interventions: Other: Implant of bilaminar chitosan scaffold

First Posted Date: 2017-09-13

Last Posted Date: 2019-03-14

Lead Sponsor: University of Guadalajara

Target Recruit Count: 1

Registration Number: NCT03280849

Locations: 🇲🇽
Departamento de neurociencias, Guadalajara, Jalisco, Mexico

Pirfenidone Plus M-DDO Gel in Moderate and Severe Acne

Phase 1

Completed

Conditions: Acne Vulgaris Superficial Mixed Comedonal and Inflammatory

Interventions: Combination Product: PDF+M-DDO
Combination Product: A+PBO

First Posted Date: 2017-03-10

Last Posted Date: 2023-07-06

Lead Sponsor: University of Guadalajara

Target Recruit Count: 82

Registration Number: NCT03076320

Locations: 🇲🇽
Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico

Effect of Berberine Versus Metformin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Prediabetes

Phase 4

Conditions: Impaired Glucose Tolerance
Impaired Fasting Glucose
Prediabetes

Interventions: Dietary Supplement: Berberine
Drug: Metformin

First Posted Date: 2017-01-24

Last Posted Date: 2023-05-23

Lead Sponsor: University of Guadalajara

Target Recruit Count: 28

Registration Number: NCT03029390

Locations: 🇲🇽
Instituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara, Guadalajara, Jalisco, Mexico

Effect of Dapagliflozin on Blood Pressure Variability in Prediabetes and Prehypertension

Phase 4

Completed

Conditions: PreDiabetes
Prehypertension

Interventions: Drug: Placebo - Cap
Drug: Dapagliflozin

First Posted Date: 2016-12-30

Last Posted Date: 2020-11-09

Lead Sponsor: University of Guadalajara

Target Recruit Count: 30

Registration Number: NCT03006471

Locations: 🇲🇽
Instituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara, Guadalajara, Jalisco, Mexico

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy